PATENT CLAIM ANALYSIS

Application Number: 16031102
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "489000"]

Abstract:
The present invention concerns a method for making an inhaled pharmaceutical composition with improved powder handling properties comprising a stearate, a method of preparing such a composition, and the use of such a stearate in a composition when dispensed into a receptacle for use in a dry powder inhaler receptacle.

Claim (Index 17):
The composition of  claim 15 , wherein the micronized pharmaceutically active material is selected from any of budesonide, formoterol fumarate, glycopyrronium bromide, indacaterol maleate, umeclidinium bromide, vilanterol trifenatate, tiotropium bromide, salmeterol xinafoate, fluticasone propionate, and combinations thereof.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 95.0
- Lexical Diversity: 1.55882
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14607289', '13078057', '10571146', '10257790', '15351562']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7742035850825678
- 35 USC 102 Novelty (BERT): 0.5235104018555776
- Combined Prediction Score: 0.7491342667598688
- Mean Citation Score: 307.197718
- Max Citation Score: 322.9940200000001
- Similarity Product: 213.6389361562801

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test